STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionMay 8, 2026, 06:02 AM

Pharvaris Prices $115M Public Offering of Ordinary Shares

AI Summary

Pharvaris N.V. announced the pricing of an underwritten public offering of 3,874,664 ordinary shares at $29.68 per share. The offering is expected to generate gross proceeds of approximately $115 million for the company, excluding any exercise of the underwriters' option. The underwriters have a 30-day option to purchase up to an additional 581,199 shares. The offering is anticipated to close around May 11, 2026.

Key Highlights

  • Pharvaris priced an underwritten offering of 3,874,664 ordinary shares.
  • The offering price is $29.68 per share.
  • Gross proceeds are expected to be approximately $115 million.
  • Underwriters have a 30-day option to purchase up to an additional 581,199 ordinary shares.
  • The offering is expected to close on or about May 11, 2026.
  • Morgan Stanley, Leerink Partners, Cantor, and Wells Fargo Securities are joint book-running managers.
PHVS
Biotechnology: Pharmaceutical Preparations
Pharvaris N.V.

Price Impact